Asset
LENIOLISIB PHOSPHATE
Pharming Group N.V. ADS each representing 10 ordinary shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02859727 | phase2_3 | terminated | 2016-09-08 | 2025-01-30 | Pharming Technologies B.V. | Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 217759 | NDA | PHARMING TECHNOLOGIES BV |
Marketed products (1)
- JOENJA